FDA Adverse Event Malfunction Summary report: N

VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK

MDR report key: 15414152 · Received September 13, 2022

Report

Report Number
3007111389-2022-00085
Event Type
Malfunction
Date Received
September 13, 2022
Date of Event
August 15, 2022
Report Date
September 13, 2022
Manufacturer
ORTHO-CLINICAL DIAGNOSTICS
Product Code
CEW
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

THE INVESTIGATION DETERMINED THAT HIGHER THAN EXPECTED VITROS INTACT PTH (IPTH) RESULTS OBTAINED WHEN TESTED USING A NON-VITROS THERMOFISHER OMNI-IMMUNE QUALITY CONTROL (QC) FLUID ON TWO DIFFERENT VITROS XT 7600 INTEGRATED SYSTEMS. THE MOST LIKELY ASSIGNABLE CAUSE FOR THE HIGHER THAN EXPECTED, INTACT PTH (IPTH) RESULT IS AN ISSUE ISOLATED TO THE PREPARATION OF THE QC FLUIDS. THERE IS NO INDICATION THAT THE VITROS ECI INTEGRATED SYSTEM OR THE VITROS IPTH REAGENT MALFUNCTIONED IN ANY WAY. (B)(4).

Description of Event or Problem · 0

A CUSTOMER CONTACTED THE ORTHO CLINICAL DIAGNOSTICS (ORTHO) TECHNICAL SOLUTION CENTER (TSC) TO REPORT HIGHER THAN EXPECTED VITROS INTACT PTH (IPTH) RESULTS OBTAINED WHEN TESTED USING A NON-VITROS THERMOFISHER OMNI-IMMUNE QUALITY CONTROL (QC) FLUID ON TWO DIFFERENT VITROS XT 7600 INTEGRATED SYSTEMS. (B)(6). BIASED RESULTS OF THE MAGNITUDE AND DIRECTION OBSERVED MAY LEAD TO INAPPROPRIATE PHYSICIAN ACTION IF THEY WERE TO OCCUR UNDETECTED ON PATIENT SAMPLES. THE HIGHER THAN EXPECTED, VITROS IPTH RESULTS WERE NOT REPORTED FROM THE LABORATORY. ORTHO HAS NOT BEEN MADE AWARE OF ANY ALLEGATION OF HARM AS A RESULT OF THIS EVENT. THIS REPORT IS NUMBER ONE OF TWO MDR¿S FOR THIS EVENT. TWO 3500A FORMS ARE BEING SUBMITTED FOR THIS EVENT AS TWO DEVICES WERE INVOLVED. THIS REPORT CORRESPONDS TO ORTHO CLINICAL DIAGNOSTICS INC (ORTHO) COMPLAINT NUMBER (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1969901 VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK IN-VITRO DIAGNOSTICS CEW ORTHO-CLINICAL DIAGNOSTICS 1550

Patients

Seq Age Sex Outcome Treatment
1 Unknown